Epidural spread of surgical site infection from spinal cord stimulation trial.
Taif J MukhdomiBennett AndrassySemih GungorPublished in: Pain management (2024)
We present a case of deep surgical site infection (SSI) at a spinal cord stimulator (SCS) trial implantation site, resulting from an allergic reaction to an unknown agent. A 38-year-old female with complex regional pain syndrome began an SCS trial, noting 100% pain relief for 5 days. Fluid drainage from the surgical site was reported on POD6 and trial leads were removed the following day. The patient was hospitalized with sepsis. Blood cultures revealed Staphylococcus aureus . MRIs showed skin breakdown and cellulitis of the paraspinal musculature extending into the epidural space. The patient was maintained with antibiotics and rigorous wound care for 9 days and the surgical site infection resolved. The patient proceeded to SCS implantation, and reported good pain relief with the implanted device.
Keyphrases
- surgical site infection
- spinal cord
- neuropathic pain
- phase iii
- study protocol
- phase ii
- staphylococcus aureus
- case report
- clinical trial
- chronic pain
- pain management
- spinal cord injury
- healthcare
- open label
- intensive care unit
- randomized controlled trial
- palliative care
- escherichia coli
- wound healing
- pseudomonas aeruginosa
- double blind
- biofilm formation